A phase II trial of adjuvant low-dose total body irradiation in non-hodgkin's lymphoma patients following standard CHOP

By Safwat Akmal   Bayoumi Yasser   Akkoush Hany   Mahmoud Hossam  

Acta Oncologica, Vol. 43, Iss. 5, 2004-07 ,pp. : 480-485

Informa Healthcare

Access to resources Recommend Favorite

Comment on “Phase II Study of Weekly Low-Dose Paclitaxel for Relapsed and Refractory Non-Hodgkin's Lymphoma: A Wisconsin Oncology Network Study,” by Kahl et al., Cancer Investig.igation , 2005, 23(1), pp. 13–18

By Smith Mitchell   Borghaei Hossein  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 572-572

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Letter to the Editor In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation

By Dubray B.   Breton C.   Delic J.   Klijanienko J.   Maciorowski Z.   Vielh P.   Fourquet A.   Dumont J.   Magdelenat H.   Cosset J. M.  

International Journal of Radiation Biology, Vol. 72, Iss. 6, 1997-12 ,pp. : 759-760

Informa Healthcare

Access to resources Recommend Favorite

Non-Hodgkin's lymphoma

By Patte C.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 359-362

Elsevier

Access to resources Recommend Favorite